US 9192628
Treatment method for relapsing-remitting multiple sclerosis
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 9192628 (Treatment method for relapsing-remitting multiple sclerosis) held by REGENEX LLC expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENEX LLC
- Grant date
- Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K40/11, A61K40/22